Clinical trials
Active, not recruiting Phase 1/2 Melanoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| National Cancer Institute (NCI) | 2 |
| April Salama, M.D. | 1 |
| Arvinas Inc. | 1 |
| Ascentage Pharma Group Inc. | 1 |
| BeiGene | 1 |
| BioAtla, Inc. | 1 |
| BioInvent International AB | 1 |
| Cancer Research UK | 1 |
| Dan Zandberg | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 30 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Carcinoma, Renal Cell | 6 |
| Neoplasms | 6 |
| Colorectal Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Neoplasm Metastasis | 4 |
| Pancreatic Neoplasms | 4 |
| Sarcoma | 4 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.